Skip to main content
. 2012 Oct 5;53(6):1128–1135. doi: 10.3349/ymj.2012.53.6.1128

Table 4.

Correlation of Baseline Characteristics and Genetic Polymorphism with Response to EGFR-TKIs

graphic file with name ymj-53-1128-i004.jpg

TKI, tyrosine kinase inhibitor; SNP, single nucleotide polymorphism; CA-SSR1, CA simple sequence repeat in intron 1; EGFR, epidermal growth factor receptor; RR, response rate; DCR, disease-control rate.